Your browser doesn't support javascript.
loading
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance.
Paoletti, Costanza; Larios, Jose M; Muñiz, Maria C; Aung, Kimberly; Cannell, Emily M; Darga, Elizabeth P; Kidwell, Kelley M; Thomas, Dafydd G; Tokudome, Nahomi; Brown, Martha E; Connelly, Mark C; Chianese, David A; Schott, Anne F; Henry, N Lynn; Rae, James M; Hayes, Daniel F.
Afiliação
  • Paoletti C; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA. Electronic address: pcostanz@med.umich.edu.
  • Larios JM; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Muñiz MC; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Aung K; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Cannell EM; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Darga EP; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Kidwell KM; Center for Cancer Biostatistics, Department of Biostatistics, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Thomas DG; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Tokudome N; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Brown ME; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Connelly MC; Janssen Pharmaceutical, Johnson & Johnson Co., Huntingdon Valley, PA, 19006, USA.
  • Chianese DA; Janssen Pharmaceutical, Johnson & Johnson Co., Huntingdon Valley, PA, 19006, USA.
  • Schott AF; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Henry NL; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Rae JM; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
  • Hayes DF; Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, 48109, USA.
Mol Oncol ; 10(7): 1078-85, 2016 08.
Article em En | MEDLINE | ID: mdl-27178224
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Estrogênio / Resistencia a Medicamentos Antineoplásicos / Estradiol / Células Neoplásicas Circulantes Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Estrogênio / Resistencia a Medicamentos Antineoplásicos / Estradiol / Células Neoplásicas Circulantes Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article